论文部分内容阅读
药品行政保护条例和实施细则已于1993年1月1日起施行,根据中美知识产权谅解备忘录,中国将对有双边协议的国家的符合条件的药品实行行政保护。我国国务院责成国家医药管理局拟定《药品行政保护条例》及其实施细则,该条例已于1992年12月12日由国务院国函(1992)193号文批复,由国家医药管理局发布实施。该条例的实施细则于1992年12月30日由国家医药管理局第13号局长令发布施行。药品行政保护,由国家医药管理局药品行政保护办公室负责受理和审批,外国药品独占权
The Regulations and Regulations on the Administration of Pharmaceutical Products came into force on January 1, 1993. Under the memorandum of understanding on intellectual property between China and the United States, China will impose administrative protection on eligible pharmaceuticals in countries with bilateral agreements. China’s State Council instructed the State Pharmaceutical Administration to formulate the Regulations on the Administration of Drugs and its Implementing Rules, which was approved by State Council (1992) No. 193 on December 12, 1992 and promulgated by the State Pharmaceutical Administration. The implementation of the Ordinance on December 30, 1992 by the State Pharmaceutical Administration No. 13 issued by the Secretary for implementation. Drug administrative protection, by the State Administration of Drug Administration Office is responsible for accepting and approval of foreign drug monopoly